Porth Ymchwil

Issues Related to the Frequency of Exploratory Analyses by Evidence Review Groups in the NICE Single Technology Appraisal Process

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

StandardStandard

Issues Related to the Frequency of Exploratory Analyses by Evidence Review Groups in the NICE Single Technology Appraisal Process. / Kaltenthaler, Eva; Carroll, Christopher; Hill-McManus, Daniel et al.
Yn: PharmacoEconomics - Open, Cyfrol 1, Rhif 2, 06.2017, t. 99-108.

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

HarvardHarvard

Kaltenthaler, E, Carroll, C, Hill-McManus, D, Scope, A, Holmes, M, Rice, S, Rose, M, Tappenden, P & Woolacott, N 2017, 'Issues Related to the Frequency of Exploratory Analyses by Evidence Review Groups in the NICE Single Technology Appraisal Process', PharmacoEconomics - Open, cyfrol. 1, rhif 2, tt. 99-108. https://doi.org/10.1007/s41669-016-0001-4

APA

Kaltenthaler, E., Carroll, C., Hill-McManus, D., Scope, A., Holmes, M., Rice, S., Rose, M., Tappenden, P., & Woolacott, N. (2017). Issues Related to the Frequency of Exploratory Analyses by Evidence Review Groups in the NICE Single Technology Appraisal Process. PharmacoEconomics - Open, 1(2), 99-108. https://doi.org/10.1007/s41669-016-0001-4

CBE

Kaltenthaler E, Carroll C, Hill-McManus D, Scope A, Holmes M, Rice S, Rose M, Tappenden P, Woolacott N. 2017. Issues Related to the Frequency of Exploratory Analyses by Evidence Review Groups in the NICE Single Technology Appraisal Process. PharmacoEconomics - Open. 1(2):99-108. https://doi.org/10.1007/s41669-016-0001-4

MLA

Kaltenthaler, Eva et al. "Issues Related to the Frequency of Exploratory Analyses by Evidence Review Groups in the NICE Single Technology Appraisal Process". PharmacoEconomics - Open. 2017, 1(2). 99-108. https://doi.org/10.1007/s41669-016-0001-4

VancouverVancouver

Kaltenthaler E, Carroll C, Hill-McManus D, Scope A, Holmes M, Rice S et al. Issues Related to the Frequency of Exploratory Analyses by Evidence Review Groups in the NICE Single Technology Appraisal Process. PharmacoEconomics - Open. 2017 Meh;1(2):99-108. doi: 10.1007/s41669-016-0001-4

Author

Kaltenthaler, Eva ; Carroll, Christopher ; Hill-McManus, Daniel et al. / Issues Related to the Frequency of Exploratory Analyses by Evidence Review Groups in the NICE Single Technology Appraisal Process. Yn: PharmacoEconomics - Open. 2017 ; Cyfrol 1, Rhif 2. tt. 99-108.

RIS

TY - JOUR

T1 - Issues Related to the Frequency of Exploratory Analyses by Evidence Review Groups in the NICE Single Technology Appraisal Process

AU - Kaltenthaler, Eva

AU - Carroll, Christopher

AU - Hill-McManus, Daniel

AU - Scope, Alison

AU - Holmes, Michael

AU - Rice, Stephen

AU - Rose, Micah

AU - Tappenden, Paul

AU - Woolacott, Nerys

PY - 2017/6

Y1 - 2017/6

N2 - Evidence Review Groups (ERGs) critically appraise company submissions as part of the National Institute for Health and Care Excellence (NICE) Single Technology Appraisal (STA) process. As part of their critique of the evidence submitted by companies, the ERGs undertake exploratory analyses to explore uncertainties in the company's model. The aim of this study was to explore pre-defined factors that might influence or predict the extent of ERG exploratory analyses.

AB - Evidence Review Groups (ERGs) critically appraise company submissions as part of the National Institute for Health and Care Excellence (NICE) Single Technology Appraisal (STA) process. As part of their critique of the evidence submitted by companies, the ERGs undertake exploratory analyses to explore uncertainties in the company's model. The aim of this study was to explore pre-defined factors that might influence or predict the extent of ERG exploratory analyses.

U2 - 10.1007/s41669-016-0001-4

DO - 10.1007/s41669-016-0001-4

M3 - Article

VL - 1

SP - 99

EP - 108

JO - PharmacoEconomics - Open

JF - PharmacoEconomics - Open

SN - 2509-4254

IS - 2

ER -